The group’s distribution division of human and veterinary APIs, SUANFARMA S.A. is one of the 500 leading companies in Business Growth during 2019, due to its results in recent years and the ability to generate added value, employment, innovation and international projection.Continue reading
SUANFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.
As developers and manufacturers of life saving drugs, it is essential for us to keep our day-to-day activities even during this challenging health crisis. Moreover, we have identified solutions to increase our capacities to be able to help to other companies or health agencies with additional medicine supplies if required.Continue reading
Cipan has received the certification of the environmental management system according to the ISO 14001 standard.Continue reading
SUANFARMA Italy based in Rovereto and specialized in the manufacture of active pharmaceutical ingredients, obtains the Top Employer certification for 2020.Continue reading
As every year, it has been a success. Thank you for joining us. The SUANFARMA teamContinue reading
SUANFARMA Group, a leading company in the development, production and distribution of active pharmaceutical ingredients for human and animal health use, today announced it has entered into a binding contractual commitment for the intended purchase of Sandoz Industrial Products S.p.A, an API manufacturing facility in Rovereto, Italy, as part of a continuing expansion of its global footprint.Continue reading
As every year SUANFARMA group will be present at CPhI Worldwide, the World´s Leading Pharmaceutical Platform which hosts more than 45,000 visiting pharma professionals and more than more than 2,500 exhibitors from 153 countries for three days.Continue reading